Pharmaseed is Israel’s largest GLP-certified pre-clinical CRO specializing in translational and regenerative studies. We are equipped for the execution of studies of NCEs, biologics and medical-devices and follow them from the development stage to first-in-man trials. These include safety and efficacy evaluation in various animal models as well as complementary in-vitro/ex-vivo models and on-site human anatomy services.
Our expertise in pre-clinical studies lies mostly in the following areas: Stem cell and cellular therapeutics, Angiogenesis, Cancer, Inflammation, CNS, Pain, Metabolic Disorders, Toxicology and Medical Devices.
Founded in 2003, Pharmaseed is a GLP-certified contract research organization (CRO) providing pre-clinical and consulting services for medical device, biotechnology and pharmaceutical companies. We also provide pre-formulation services for small and medium-size start-ups as well as idea and feasibility companies.
Pharmaseed’s lean and experienced team forms an efficient organization whose global reach includes a network of sponsors from the U.S., Europe, Canada and Israel. This network has enabled Pharmaseed to establish JV programs with pharmaceutical companies and academia as well as a top-tier S.A.B./K.O.L. panel from multinational bio-pharma companies.
All our services are priced at a competitive rate in comparison to European and U.S.-based companies.